Cargando…

Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007–13) and prospective (2014–18) MIDAS sales data analysis

BACKGROUND: Health Canada has defined rare diseases as life-threatening, seriously debilitating, or serious chronic conditions affecting a very small number of patients (~1 in 2,000 persons). An estimated 9 % of Canadians suffer from a rare disease. Drugs treating rare diseases (DRDs) are also known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Divino, Victoria, DeKoven, Mitch, Kleinrock, Michael, Wade, Rolin L., Kim, Tony, Kaura, Satyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875716/ https://www.ncbi.nlm.nih.gov/pubmed/27207271 http://dx.doi.org/10.1186/s13023-016-0450-y

Ejemplares similares

Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020)

The economic burden of CIDP in the United States: A case-control study
por: Divino, Victoria, et al.
Publicado: (2018)

Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations
por: Bhosle, Monali, et al.
Publicado: (2009)

GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data
por: Divino, Victoria, et al.
Publicado: (2019)

GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries
por: Divino, Victoria, et al.
Publicado: (2017)

PIN75 Characteristics of Patients Diagnosed with COVID-19 in the US: A Descriptive Claims-Based Study from a National Perspective
por: Divino, V., et al.
Publicado: (2020)

1255. Single-tablet Regimens (STR) Offer Better Persistence and Adherence, with Lower Costs by Adherence Status, than Multiple-tablet Regimens (MTR) for People Living with HIV (PLWH) Enrolled in Medicaid
por: Brogan, Andrew P, et al.
Publicado: (2022)

1254. An Increase in Single-tablet Regimen (STR) Utilization for People Living with HIV (PLWH) Enrolled in Medicaid had Minimal Impact on Pharmacy Costs
por: Brogan, Andrew P, et al.
Publicado: (2022)

Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes
por: Mocarski, Michelle, et al.
Publicado: (2018)

Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries
por: Divino, Victoria, et al.
Publicado: (2014)

Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season
por: Pelton, Stephen I., et al.
Publicado: (2020)

Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis
por: Zimner Rapuch, Sarah, et al.
Publicado: (2021)

Health-Care Resource Utilization and Treatment Patterns in Men with Erectile Dysfunction and Benign Prostatic Hyperplasia-Associated Lower Urinary Tract Symptoms in the United States: A Retrospective Database Study
por: Goldstein, Irwin, et al.
Publicado: (2023)

Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018–19 Influenza Season in the United States
por: Krishnarajah, Girishanthy, et al.
Publicado: (2021)

Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis
por: Levin, Myron J., et al.
Publicado: (2021)

Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study
por: Divino, Victoria, et al.
Publicado: (2021)

A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019–2020 Influenza Season in the United States
por: Divino, Victoria, et al.
Publicado: (2021)

The Pharmaceutical Society and the Sale of Laudanum
Publicado: (1916)

Changing direction: a practical approach to directing actors in film and theatre
por: DeKoven, Lenore
Publicado: (2006)

Probabilistic data linkage: a case study of comparative effectiveness in COPD
por: Blanchette, Christopher M, et al.
Publicado: (2013)

Clinical and cost outcomes from different hyaluronic acid treatments in patients with knee osteoarthritis: evidence from a US health plan claims database
por: Dasa, Vinod, et al.
Publicado: (2016)

Disability and migraine: MIDAS
por: D’Amico, Domenico, et al.
Publicado: (2001)

The MIDAS SDAI implementation
por: Thomas, D, et al.
Publicado: (1996)

14. A Comprehensive Real-World Analysis to Compare Adjuvanted Trivalent Influenza Vaccine and Trivalent High Dose Influenza Vaccine by Age and Period of High Influenza Activity for the 2018–19 Season among U.S. Elderly
por: Postma, Maarten, et al.
Publicado: (2020)

PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES
por: Zeidan, A., et al.
Publicado: (2022)

Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide
por: DeKoven, Mitch, et al.
Publicado: (2014)

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
por: Dranitsaris, George, et al.
Publicado: (2015)

Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis
por: Burudpakdee, Chakkarin, et al.
Publicado: (2015)

Las Culpas de Midas
por: Aspe, Pieter, 1953-
Publicado: (2010)

Botulinum toxin: The Midas touch
por: Shilpa, P. S., et al.
Publicado: (2014)

B(MIDA)-Containing Diborons
por: Yoshida, Hiroto, et al.
Publicado: (2017)

6. MF59 ASSURANCE 2: A Real-world Study to Estimate the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-based Trivalent High-dose Among U.S. Older Adults During 2018–19 Influenza Season
por: Pelton, Stephen I, et al.
Publicado: (2020)

29. Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018–19 Influenza Season
por: Postma, Maarten, et al.
Publicado: (2020)

Complex formulations, simple techniques: Can 3D printing technology be the Midas touch in pharmaceutical industry?
por: Lamichhane, Shrawani, et al.
Publicado: (2019)

El toque de Midas = Midas touch : todo lo que toca --- se convierte en oro /
Publicado: (2005)

25. Relative Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-Based Trivalent High-Dose Influenza Vaccine among U.S. Older Adults during 2019-20 Influenza Season
por: levin, myron J, et al.
Publicado: (2021)

State tobacco control expenditures and tax paid cigarette sales
por: Tauras, John A., et al.
Publicado: (2018)

Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes
por: Zhou, Fang Liz, et al.
Publicado: (2018)

MIDA boronate allylation – synthesis of ibuprofen
por: Phillips, David, et al.
Publicado: (2020)

Ethical considerations for mystery shopper studies of pharmaceutical sales
por: Collins, Jack C, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qf88c48i06e2oudl51a7igl4ks